In den Warenkorb
Bestellen Sie auch über:
![]() |
+49 (0)241 95 163 153 |
![]() |
+49 (0)241 95 163 155 |
Tumor Protein P53 (TP53) Antikörper
| Antigen | Tumor Protein P53 (TP53) |
| Synonyme | p53, LFS1, TRP53, FLJ92943, P53, Trp53, MGC112612, brp53, drp53, fb40d06, wu:fb40d06, zgc:111919, TP53, bbl, bfy, bhy, p44, Tp53, tp53 |
| Klonalität | Monoklonal (BP53-12) |
| Wirt |
Alternativen Maus |
| Reaktivität |
Alternativen Human, Primaten |
| Applikation |
Alternativen Immunpräzipitation (IP), Western Blot (WB), Immunhistochemie (Paraffinschnitte) (IHC (p)), ELISA, Immunzytochemie (ICC)
|
| Produktnummer | ABIN94448 |
| Menge | 0.1 mg (1 mg/ml) (Varianten) |
| Preis | 190,00 € Zzgl. Versandkosten €20,00 und MWSt |
| Lieferung nach |
|
| Verfügbarkeit | Lieferung in 3 bis 5 Werktagen |
Produktbeschreibung
| Weitere Bezeichnung | p53 |
| Immunogen | Bacterially expressed full-length wild-type p53 |
| Format | Purified |
| Isotyp | IgG2a (Passende Sekundärantikörper) |
| Klon | BP53-12 |
| Beschreibung | The tumour suppressor protein p53 is a key element of intracellular anticancer protection. Itmediates cell cycle arrest or apoptosis in response to DNA damage or to starvation forpyrimidine nukleotides. It is up-regulated in response to these stress signals and stimulatedto activate transcription of specific genes, resulting in expression of p21waf1 and otherproteins involved in G1 or G2/M arrest, or proteins that trigger apoptosis, such as Bcl-2. Thestructure of p53 comprises N-terminal transactivation domain, central DNA-binding domain,oligomerisation domain, and C-terminal regulatory domain. There are variousphosphorylation sites on p53, of which the phosphorylation at Ser15 is important for p53activation and stabilization. |
| Spezifität | The antibody BP53-12 recognizes defined epitope (aa 16-25) on human p53, a 50 kDatumour suppressor found in increased amounts in a wide variety of transformed cells, it isfrequently mutated or inactivated in many types of cancer. |
Anwendungen
| Applikationshinweise | Western Blotting - Recommended dilution: 1-2 µg/ml, overnight in 4 o C Positive control: RAMOS human lymphoma cell line. Sample preparation: Resuspend approx. 50 mil. cells in 1 ml cold Lysis buffer (1%laurylmaltoside in 20 mM Tris/Cl, 100 mM NaCl pH 8. 2, 50 mM NaF including Proteaseinhibitor Cocktail). Incubate 60 min on ice. Centrifuge to remove cell debris. Mix lysate withnon-reducing SDS-PAGE sample buffer. Application note: Non-reducing conditions. SDS-PAGE (12% separating gel). |
| Konzentration | 1 mg/ml |
| Reinheit | > 95% (by SDS-PAGE) |
| Reinigung | Purified from ascites by precipitation methods. |
| Buffer | Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.4 |
| Lagerung | Store at 2-8 o C. Do not use after expiration date stamped on vial label. For long-term storage aliquot and store at -20 o C. Avoid freeze/thaw cycles. |
| Forschungsgebiet | Krebs, Zellzyklus, Transkriptionsfaktoren, DNS/RNS, Apoptose/Nekrose |
| Beschränkungen | Nur für Forschungszwecke einsetzbar |
Bilder
Alternativen
Alternativen zu Antigen "Tumor Protein P53 (TP53)", Typ "Antikörper" finden




Alternativen